MWNA
CEMI

Marshall Wace North America’s Chembio diagnostics, Inc. CEMI Stock Holding History

Marshall Wace North America’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,224
Closed -$20K – 1772
2019
Q3 		$20K Buy
+3,224
New +$19.2K ﹤0.01% 1233
2019
Q2 		– Sell
-8,612
Closed -$48K – 1882
2019
Q1 		$48K Buy
+8,612
New +$55.9K ﹤0.01% 1272

Other funds holding CEMI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace North America's CEMI Position: Q4 2019 in Review

Marshall Wace North America sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2019, closing a stake of 3,224 shares — an estimated $20K sold.

Marshall Wace North America first reported a position in CEMI in Q1 2019 and held it in 2 quarters. The position peaked at $48K in Q1 2019. 39 funds tracked by Wall St. Rank hold CEMI as of Q4 2019.

  • Marshall Wace North America reported no remaining Chembio diagnostics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Marshall Wace North America sold 3,224 Chembio diagnostics, Inc. shares in Q4 2019, an estimated $20K.
  • Marshall Wace North America first reported a position in Chembio diagnostics, Inc. in Q1 2019 and held it in 2 quarters.
  • Marshall Wace North America's Chembio diagnostics, Inc. position peaked at $48K in Q1 2019.
  • 39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.